Hot Stock for Investors: Globus Medical, Inc. (GMED)

Leslie Hanson
January 13, 2018

The Company's deposit products include interest-bearing deposits comprising savings, NOW, and money market accounts, as well as time certificates of deposit; and non-interest bearing demand deposits. The original version of this story can be accessed at (NYSE:GMED) is a huge mover today!

The stock increased 3.20% or $1.37 during the last trading session, reaching $44.12. About 176,081 shares traded.

Investment analysts at William Blair boosted their Q4 2018 earnings per share estimates for shares of Globus Medical in a research note issued on Tuesday. It has outperformed by 14.18% the S&P500.The move comes after 5 months negative chart setup for the $4.27B company. Ameritas Investment Prns reported 1.25% in, Inc. We have $40.76 PT which if reached, will make NYSE:GMED worth $341.52 million less. Also, insider A Brett Murphy sold 51,449 shares of Globus Medical stock in a transaction on Thursday, November 9th. Private Management Group Inc owns 616,268 shares or 0.73% of their U.S. portfolio. 814.86 million shares or 0.93% less from 822.50 million shares in 2017Q2 were reported. Missouri-based Argent Capital Management Llc has invested 0.06% in Globus Medical, Inc. Matarin Capital Management Llc, a Connecticut-based fund reported 38,679 shares.

Analysts await Central Valley Community Bancorp (NASDAQ:CVCY) to report earnings on January, 24.

In related news, President Anthony L. Williams sold 15,000 shares of the business's stock in a transaction that occurred on Wednesday, December 13th. COP's profit will be $478.21M for 37.53 P/E if the $0.40 EPS becomes a reality. The medical device company reported $0.30 earnings per share for the quarter, hitting analysts' consensus estimates of $0.30.

The stock increased 0.32% or $0.07 during the last trading session, reaching $20.55. About 388,417 shares traded. ConocoPhillips (NYSE:COP) has risen 9.50% since January 13, 2017 and is uptrending. It has outperformed by 14.18% the S&P500. (NYSE:GMED). Columbia Partners L L C Mgmt holds 0.39% of its portfolio in Globus Medical, Inc.

Several research analysts have recently commented on the company.

HOLX trades at a forward P/E of 18.48, a P/B of 4.37, and a P/S of 3.91, compared to a forward P/E of 32.22, a P/B of 4.56, and a P/S of 6.76 for GMED. During the same period in the prior year, the firm earned $0.29 earnings per share. analysts predict that Globus Medical Inc will post 1.27 EPS for the current fiscal year.

Investors sentiment decreased to 1.38 in Q3 2017. HOLX's debt-to-equity ratio is 1.20 versus a D/E of 0.00 for GMED.

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. 42 funds opened positions while 77 raised stakes. Schwab Charles Investment Inc stated it has 346,775 shares.

Globus Medical (NYSE:GMED) last issued its quarterly earnings results on Wednesday, November 8th. HOLX has a short ratio of 2.97 compared to a short interest of 6.11 for GMED.

More news for Globus Medical, Inc. (NYSE:GMED). Van Berkom & reported 1.84M shares. Wealth Architects Ltd Liability reported 1.16% stake.

Thomson Horstmann & Bryant Inc. acquired a new stake in Globus Medical Inc (NYSE:GMED) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. (GMED), there were 0 new positions totaling 0 shares of the company's stock.

The stock of PLDT Inc. Fernwood Investment Mngmt Limited Liability Company reported 28,709 shares. More interesting news about Globus Medical, Inc. (NYSE:GMED). First Personal Fincl Service has invested 0% in Globus Medical, Inc. It also upped Vanguard Inter (VWIUX) stake by 36,442 shares and now owns 2.75 million shares. Fayez Sarofim & has invested 0.79% of its portfolio in ConocoPhillips (NYSE:COP). (NYSE:GMED) or 10,337 shares.

Among 5 analysts covering Philippine Long Distance Telephone (NYSE:PHI), 4 have Buy rating, 1 Sell and 0 Hold. Therefore 60% are positive. Illinois-based Group One Trading Lp has invested 0% in Globus Medical, Inc. Globus Medical now has an average rating of "Buy" and an average price target of $40.57. Bank of America upgraded the shares of GMED in report on Friday, November 10 to "Neutral" rating. As per Friday, August 7, the company rating was initiated by Bernstein. The stock has "Hold" rating by Oppenheimer on Thursday, August 3.

They now have a $38.0 target price on Globus Medical (NYSE:GMED). The rating was downgraded by Goldman Sachs to "Sell" on Monday, May 16. The company was upgraded on Monday, December 4 by Wells Fargo. The stock has "Market Perform" rating by Wells Fargo on Wednesday, July 27. The firm has "Underweight" rating given on Thursday, October 19 by Barclays Capital. The company was maintained on Tuesday, July 18 by Piper Jaffray.

Other reports by Iphone Fresh

Discuss This Article